Heparin Induced Platelet Antibody
Desired Epic Build
* = editable field
| Cerner Primary Mnemonic: | Heparin Induced Platelet AB | ||||||||||||
| PDM | 5700180 | ||||||||||||
| Informatics - Workgroup | Hematology | ||||||||||||
| Synonyms * | ANTIBODIES HEPARIN INDUCED PLATELET ANTIBODY HIPA HITA HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODY HIT PF4 | ||||||||||||
| Display Name * | Heparin Induced Platelet Antibody | ||||||||||||
| Specimen Sources (combined Order Entry and Specimen Navigator) * | |||||||||||||
| Specimen Types (combined Order Entry and Specimen Navigator) * |
Blood
|
||||||||||||
| Body Fluids (types sent through AOEs) | |||||||||||||
| Specimen Navigator Specimen Types | |||||||||||||
| Specimen Navigator Specimen Sources | |||||||||||||
| Specimen Navigator Short Name | |||||||||||||
| Ordering info (EPIC SmartText) | Evaluation of possible immune-mediated type II heparin-induced thrombocytopenia (HIT-II) which should be suspected for the following patients: -Patients not previously exposed to heparin, the development of absolute thrombocytopenia or decrease in platelet count of ≥50% from baseline or postoperative peak with the onset of thrombocytopenia beginning approximately 5 to 10 days after initiation of heparin. This may or may not be associated with new or progressive thrombosis in patients treated with heparin. -Patients previously exposed to heparin (especially within the preceding 100 days), in addition to the above findings, the onset of thrombocytopenia could occur within 24 to 48 hours after reexposure to heparin. In patients with prior suspected or documented heparin-induced thrombocytopenia (HIT), with or without thrombosis, assay for presence of human platelet factor 4 (H/PF4) antibody may be useful in assessment of the risk of recurrence of HIT with additional exposure to heparin, however, prospective data are limited. | ||||||||||||
| IP Orderable (inpatient) | Yes | ||||||||||||
| OP Orderable (outpatient) | Yes | ||||||||||||
| AOEs * | |||||||||||||
| AP AOEs | |||||||||||||
| Special History | No | ||||||||||||
| Build Comments | |||||||||||||
| Filter * | |||||||||||||
| Cerner Site Restrict | Lenox Hill Laboratory Long Island Jewish Med Ctr North Shore University Laboratory Northwell Health Laboratories | ||||||||||||
Cerner Results
| |||||||||||||
Actual Epic Build 3/11/2025
| PROCEDURE ID | 64666 | ||||||||||||||||||||||||
| PDM | 5700180 | ||||||||||||||||||||||||
| ORDER DISPLAY NAME | Heparin Induced Platelet Antibody | ||||||||||||||||||||||||
| PROCEDURE NAME | HEPARIN-INDUCED PLATELET ANTIBODY | ||||||||||||||||||||||||
| PROCEDURE MASTER NUMBER | LAB766 | ||||||||||||||||||||||||
| SHORT PROCEDURE NAME | HEPARIN DEPENDENT ANTIBO | ||||||||||||||||||||||||
| CATEGORY CODE | 1.0 | ||||||||||||||||||||||||
| CATEGORY CODE RECORD NAME | LAB BLOOD ORDERABLES | ||||||||||||||||||||||||
| SYNONYMS | ANTIBODIES HEPARIN INDUCED PLATELET ANTIBODY HIPA HITA HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODY HIT PF4 |
||||||||||||||||||||||||
| CLINICALLY ACTIVE | Yes | ||||||||||||||||||||||||
| ORDERABLE | Yes | ||||||||||||||||||||||||
| PERFORMABLE | Yes | ||||||||||||||||||||||||
| FILTER GENOMICS | |||||||||||||||||||||||||
| REFERENCE LINK URL | https://labs.northwell.edu/epic/test/64666 | ||||||||||||||||||||||||
| ORDERING INSTRUCTIONS | |||||||||||||||||||||||||
| DEFAULT SPECIMEN TYPE | Blood | ||||||||||||||||||||||||
| SPECIMEN TYPE PICK LIST | Blood | ||||||||||||||||||||||||
| SPECIMEN TYPE LIST | |||||||||||||||||||||||||
| OP SPECIMEN TYPE LIST | |||||||||||||||||||||||||
| SPECIMEN SOURCE PICK LIST | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||||||||||||||
| SPECIMEN SOURCE DEFAULT - MALE | Blood, Venous | ||||||||||||||||||||||||
| SPECIMEN SOURCE DEFAULT - FEMALE | Blood, Venous | ||||||||||||||||||||||||
| SPECIMEN SOURCE LIST | |||||||||||||||||||||||||
| OP SPECIMEN SOURCE LIST | |||||||||||||||||||||||||
| IP LAB TEST COMPONENTS FOR REPORT | HEPPF4ABEIA HEPABINTRP |
||||||||||||||||||||||||
| OP LAB TEST COMPONENTS FOR REPORT | HEPPF4ABEIA HEPABINTRP |
||||||||||||||||||||||||
| ORDER QUESTIONS | [] | ||||||||||||||||||||||||
| ORDER QUESTIONS RECORD NAME | |||||||||||||||||||||||||
| INPATIENT ORDER QUESTIONS | [] | ||||||||||||||||||||||||
| INPATIENT ORDER QUESTIONS RECORD NAME | |||||||||||||||||||||||||
| ORDER SPECIFIC QUESTION OVERRIDE | |||||||||||||||||||||||||
| INPATIENT QUESTION OVERRIDE | |||||||||||||||||||||||||
| LOCATION RESTRICT LIST IP | |||||||||||||||||||||||||
| LOCATION RESTRICT LIST IP RECORD NAME | |||||||||||||||||||||||||
| LOCATION RESTRICT LIST INCLUDE IP | |||||||||||||||||||||||||
| LOCATION RESTRICT LIST OP | |||||||||||||||||||||||||
| LOCATION RESTRICT LIST OP RECORD NAME | |||||||||||||||||||||||||
| LOCATION RESTRICT LIST INCLUDES OP | |||||||||||||||||||||||||
| EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME | |||||||||||||||||||||||||
| EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME | |||||||||||||||||||||||||
| EDP IP SPECIMEN SOURCE | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary |
||||||||||||||||||||||||
| EDP OP SPECIMEN SOURCE | |||||||||||||||||||||||||
| EDP IP SPECIMEN TYPE | Blood | ||||||||||||||||||||||||
| EDP OP SPECIMEN TYPE | |||||||||||||||||||||||||
| DERIVED EDP IP BUTTONS S | Blood, Central Line Blood, Arterial Blood, Capillary Blood, Venous |
||||||||||||||||||||||||
| DERIVED EDP IP BUTTONS T | Blood | ||||||||||||||||||||||||
| DERIVED EDP OP BUTTONS S | |||||||||||||||||||||||||
| DERIVED EDP OP BUTTONS T | |||||||||||||||||||||||||
| IP ORDERABLE | 1 | ||||||||||||||||||||||||
| OP ORDERABLE | 1 | ||||||||||||||||||||||||
| STANDARD LAB COMPONENTS | |||||||||||||||||||||||||
| STANDARD LAB COMPONENTS RECORD NAME | |||||||||||||||||||||||||
| COMPONENT DATA REQUIREMENT | |||||||||||||||||||||||||
| EPIC OP AOEs | |||||||||||||||||||||||||
| EPIC IP AOEs | |||||||||||||||||||||||||
EPIC Components (results - crosswalked through Cerner)
| |||||||||||||||||||||||||